44 / 154
S14
A B S T R A C T S
S41
Olivier Mir
The speaker abstract has not been received at the time of
publication.
S42
Loïc Mourey
The speaker abstract has not been received at the time of
publication.
Disclosure of interest:
Sanofi Aventis: personal fees & non-
financial support; Astellas: personal fees and non-financial
support; Janssen: personal fees & non-financial support;
Pfizer: personal fees and non-financial support; Novartis:
personal fees & non-financial support; Ipsen: personal fees;
Roche: non-financial support; GSK: grant
S43
WEARABLE AND HOME SENSORS
Arash Naeim
David Geffen School of Medicine, Department of Medicine, Los
Angeles, CA, USA
As the baby boomers age and the population rapidly
increases, technology will be an important component in
assessment, monitoring, and treatment decision-making
for older adults. This presentation will review the important
research considerations in using wearable and home sensors
in older cancer patients. I will highlight the UCLA’s SMART
Home Lab, a mock residence where researchers can test the
reliability and resilience of home health sensors, as well as
the integration of sensing technology in clinical translational
research units for patient testing and validation. I will discuss
the flexibility, adaptability and mobility of wearable and
remote health systems in risk stratifying, monitoring and
delivering information to patients. This presentation is in
the context of UCLA’s new Center for SMART (Systematic,
Measurable, Actionable, Resilient and Technology-driven
Health) Health, which is fostering collaboration among
engineers, computer scientists, clinicians and biomedical
researchers. Research teams are collaborating on mobile
technology, big data analytics, screening technologies and
medical robotics in order to address challenges in the way
health care is delivered. I will share some of the Center’s
various first projects related to older cancer patients.
Disclosure of interest:
Invista Health Inc. (Founder and
Shareholder), a company focused on remote monitoring of
older individuals
S44
THE IMPACT OF RADIATION THERAPY ON THE QUALITY OF
LIFE OF OLDER PATIENTS
Anita O’Donovan
Trinity College Dublin, Discipline of Radiation Therapy, School of
Medicine, Dublin, Ireland
Approximately half of all cancer patients will require
radiotherapy at some point during the treatment trajectory,
with the majority of these being older patients. Radiation
therapy is a cancer modality that can be an excellent option
for older patients due to its limited systemic toxicity. Although
widely used, there have been limited radiation oncology
clinical trials designed specifically for the elderly, until recent
times.
Changes in modern radiotherapy delivery will also have
an impact on toxicity, with hypofractionation increasingly
used in specific sites. Patient treatment times can thus be
shortened with distinct advantages from a logistical and
socioeconomic perspective, as well as on a patient’s quality
of life. Newer treatment modalities potentially allow the
reduction of side effects through greater use of modulated
techniques and improved imaging during treatment.
Comprehensive geriatric assessment (CGA) should be
performed before radiotherapy commences in order to
establish baseline functioning and to pre-empt potential
issues that may impact quality of life. This helps to develop
a comprehensive management and care plan because it
distinguishes between age-related changes and those caused
by the radiotherapy itself. In this talk, I will discuss the vital
role of CGA and continuous supportive care for older patients
in managing the effects of radiotherapy, as well as improving
quality of life.
Radiotherapy is a safe and effective treatment option for
older adults. The risk of serious complications after radiation
therapy is small. However, radiation therapy requires an
individualised approach to ensure optimal quality of life after
treatment.
Disclosure of interest:
None declared
S45
PREHABILITATION BEFORE SURGERY
Nina Ommundsen
Oslo University Hospital, Geriatric Department, Oslo, Norway
Functional disability is an important predictor of outcome
in older cancer patients. In the time period between diagnosis
and surgery, functional capacity can be improved by a variety
of means, such as optimisation of comorbidities, improved
nutritional status and cardiopulmonary function. This
concept of prehabilitation has been utilised in the setting of
orthopaedic surgery and cardiac surgery with positive effects.
Effects have also been found in studies on older cancer
patients, but there is heterogeneity both regarding patient
selection and type of intervention.